Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566109 · ClinicalTrials.gov registry record · NA
Community Hospital Identification of High CV Risk Patients During Cancer Treatment
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02566109 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants.
The verdict
NCT02566109, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The overall of this proposal is to test in community hospitals the utility of a 10-min magnetic resonance imaging (MRI) scan protocol combined with proprietary image analysis algorithms for detecting early cardiovascular (CV) injury during receipt of chemotherapy for breast cancer (BrC) and lymphoma. This technology provides health-care delivery systems with a time-efficient method to identify those at risk of a future CV event so that prevention can be implemented to prolong survival and reduce morbidity in cancer survivors.
Interventions
- DIAGNOSTIC_TEST Fast MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-02-25 |
| Est. Completion | 2017-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02566109
The ClinicalTrials.gov registry entry for NCT02566109 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fast MRI is the first listed.
NCT02566109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02566109 about?
NCT02566109 is a clinical study titled "Community Hospital Identification of High CV Risk Patients During Cancer Treatment". The overall of this proposal is to test in community hospitals the utility of a 10-min magnetic resonance imaging (MRI) scan protocol combined with proprietary image analysis algorithms for detecting early cardiovascular (CV) injury during receipt of chemotherapy for breast cancer (BrC) and lymphoma...
What is the current status of trial NCT02566109?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-02-25. Estimated completion is 2017-10-04.
What interventions are being tested in trial NCT02566109?
The interventions under investigation include: Fast MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02566109?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.